These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 338040)

  • 21. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC; Marcuse A; Brosch M; Schüle C; Eser D; Nothdurfter C; Steng Y; Noack I; Pietschmann K; Möller HJ; Rupprecht R
    World J Biol Psychiatry; 2006; 7(2):82-90. PubMed ID: 16684680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of unilateral and bilateral ECT.
    Fleminger JJ; de Horne DJ; Nair NP; Nott PN
    Am J Psychiatry; 1970 Oct; 127(4):430-6. PubMed ID: 4918113
    [No Abstract]   [Full Text] [Related]  

  • 23. Somatic treatment for depressive illnesses in children and adolescents.
    Findling RL; Feeny NC; Stansbrey RJ; DelPorto-Bedoya D; Demeter C
    Psychiatr Clin North Am; 2004 Mar; 27(1):113-37, x. PubMed ID: 15062634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ECT and onset of action.
    Roose SP; Nobler M
    J Clin Psychiatry; 2001; 62 Suppl 4():24-6; discussion 37-40. PubMed ID: 11229784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Electroconvulsive therapy in therapy-resistant depression].
    Verwey B
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1042. PubMed ID: 8684501
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of depression in idiopathic Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S112-9. PubMed ID: 12211151
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical efficacy of unilateral ECT.
    Abrams R; DeVito RA
    Dis Nerv Syst; 1969 Apr; 30(4):262-3. PubMed ID: 4890011
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary report.
    Janicak PG; Sharma RP; Israni TH; Dowd SM; Altman E; Davis JM
    Psychopharmacol Bull; 1991; 27(3):353-7. PubMed ID: 1775610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.
    Shapira B; Lidsky D; Gorfine M; Lerer B
    J Clin Psychiatry; 1996 Jan; 57(1):32-8. PubMed ID: 8543545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis].
    Rehor G; Conca A; Schlotter W; Vonthein R; Bork S; Bode R; Hüll M; Plewnia C; Di Pauli J; Prapotnik M; Peters O; Peters J; Eschweiler GW
    Neuropsychiatr; 2009; 23(3):157-63. PubMed ID: 19703381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis.
    Warnell RL; Elahi N
    J ECT; 2007 Jun; 23(2):114-9. PubMed ID: 17548984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future brightening for depression treatments.
    Holden C
    Science; 2003 Oct; 302(5646):810-3. PubMed ID: 14593164
    [No Abstract]   [Full Text] [Related]  

  • 34. ECT in the management of major depression: implications of recent research.
    Andrade C; Nelson AI; Fink M
    World J Biol Psychiatry; 2003 Jul; 4(3):139-40; author reply 140-1. PubMed ID: 12872209
    [No Abstract]   [Full Text] [Related]  

  • 35. [Electroconvulsive therapy in late life depression: a review].
    Stek ML; Beekman AT; Verwey B
    Tijdschr Gerontol Geriatr; 1997 Jun; 28(3):106-12. PubMed ID: 9381518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of adjuvant drug therapy following successful electroconvulsive therapy for therapy-resistant depression is still disappointing].
    Leentjens AF; van den Broek WW; Birkenhäger TK; Moleman P; Bruijn JA
    Ned Tijdschr Geneeskd; 1996 Feb; 140(5):241-3. PubMed ID: 8643129
    [No Abstract]   [Full Text] [Related]  

  • 37. Lithium augmentation therapy in refractory depression-update 2002.
    Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: the cognitive effects of ECT in community settings.
    Abrams R
    J ECT; 2007 Jun; 23(2):68. PubMed ID: 17548971
    [No Abstract]   [Full Text] [Related]  

  • 39. Electroconvulsive therapy in New Zealand: terrifying or electrifying?
    Melding P
    N Z Med J; 2006 Jul; 119(1237):U2051. PubMed ID: 16862197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ECT and antidepressants.
    Peterson GN
    J Clin Psychiatry; 1988 Nov; 49(11):455. PubMed ID: 3053670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.